4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-009205
General Counsel sold 52 shares at an average $9.50 ($494)
From the SEC's structured data for this filing
Trades in this filing
Miller Edward · General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-23 | Sale : show line 1 in the form | −47 | $9.45 | $444 | 6,628 | D |
| 2025-01-23 | Sale : show line 2 in the form | −5 | $9.94 | $50 | 6,623 | D |
| Open-market sales · 52 sh · avg $9.50 · $494 | ||||||
Loading xslF345X05/ownership.xml…